» Articles » PMID: 29285128

The Relationship Between Inflammatory Mediator Expression in the Aqueous Humor and Secondary Glaucoma Incidence After Silicone Oil Tamponade

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2017 Dec 30
PMID 29285128
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of inflammatory mediators in the aqueous humor and the incidence of secondary glaucoma after vitreous body resection combined with silicone oil tamponade for patients with retinal detachment were inestigated, and the roles of IL-17, IL-6 and TNF-α in secondary glaucoma after silicone oil tamponade were analyzed. Fifty-eight cases of retinal detachment treated by vitrectomy combined with silicone oil tamponade were examined at the time of silicone oil removal surgery. All patients underwent unilateral surgery. Patients were divided into observation (19 cases with) and control (39 cases without) groups depending on development of secondary glaucoma. Prior to silicone oil removal, expression levels of IL-17, IL-6 and TNF-α in the aqueous humor were examined. IL-17, IL-6 and TNF-α levels in the aqueous humor in the observation group were 204.2±18.3, 351.1±28.4 and 850.0±51.7 pg/ml, respectively, vs. 152.3±22.2, 254.4±26.8 and 625.6±61.2 pg/ml, respectively in the control group (P<0.001). The expression of IL-17 was positively correlated with those of IL-6 and TNF-α (r=0.687, 0.745; P<0.001). IL-17, IL-6 and TNF-α presented good diagnostic values for glaucoma. The receiver operating characteristic (ROC) areas were 0.957, 0.980 and 0.975, respectively (P<0.001). The expression of inflammatory mediators such as IL-17, IL-6 and TNF-α in the aqueous humor of patients with secondary glaucoma after silicone oil tamponade significantly increased relative to patients without secondary glaucoma. The resultant inflammation may be involved in the development of secondary glaucoma.

Citing Articles

A characterization study of the anterior segment morphology of patients with and without long-term silicone oil following vitrectomy.

Singh G, Lee Y, Sun M, Selva D, Chan W Int Ophthalmol. 2025; 45(1):37.

PMID: 39853508 PMC: 11762219. DOI: 10.1007/s10792-025-03407-7.


Ophthalmic Outcomes After Silicone Oil Removal.

Jiao G, Shah P, Shakin E, Lee J, Ferrone P, Rhee D J Vitreoretin Dis. 2024; :24741264241271645.

PMID: 39554621 PMC: 11561951. DOI: 10.1177/24741264241271645.


CO laser-assisted sclerectomy surgery for secondary open-angle glaucoma after vitrectomy.

Li Z, Wang A, Zhu M, Zhou N, Liu L, Li Q Front Med (Lausanne). 2024; 11:1429791.

PMID: 39139788 PMC: 11319287. DOI: 10.3389/fmed.2024.1429791.


Apoptosis in glaucoma: A new direction for the treatment of glaucoma (Review).

Xia Q, Zhang D Mol Med Rep. 2024; 29(5).

PMID: 38516770 PMC: 10975112. DOI: 10.3892/mmr.2024.13207.


Risk Factors and Management of Intraocular Pressure Elevation After Vitrectomy Combined with Silicone Oil Tamponade.

Ge L, Su N, Fan W, Yuan S Int J Gen Med. 2024; 17:447-456.

PMID: 38333017 PMC: 10849908. DOI: 10.2147/IJGM.S446617.


References
1.
Guo X, Tian B, Liu Z, Wei W, Tao Y, Sun S . A new rat model of glaucoma induced by intracameral injection of silicone oil and electrocoagulation of limbal vessels. Chin Med J (Engl). 2011; 124(2):309-14. View

2.
Miller J, Papakostas T, Vavvas D . Complications of emulsified silicone oil after retinal detachment repair. Semin Ophthalmol. 2014; 29(5-6):312-8. DOI: 10.3109/08820538.2014.962181. View

3.
Ichhpujani P, Jindal A, Katz L . Silicone oil induced glaucoma: a review. Graefes Arch Clin Exp Ophthalmol. 2009; 247(12):1585-93. DOI: 10.1007/s00417-009-1155-x. View

4.
Speeckaert R, Lambert J, Grine L, Van Gele M, de Schepper S, van Geel N . The many faces of interleukin-17 in inflammatory skin diseases. Br J Dermatol. 2016; 175(5):892-901. DOI: 10.1111/bjd.14703. View

5.
Zoric Geber M, Bencic G, Vatavuk Z, Ivekovic R, Friberg T . Retinal nerve fibre layer thickness measurements after successful retinal detachment repair with silicone oil endotamponade. Br J Ophthalmol. 2014; 99(6):853-8. DOI: 10.1136/bjophthalmol-2014-305839. View